Little Imane Diakité, just 7 years old, looks like any other girl her age. However, she is one of the nearly 100,000 Americans living with sickle cell anemia, a genetic disease that causes a malformation of red blood cells, leading to poor blood circulation throughout the body.

The disease, characterized by crescent-shaped red blood cells, is caused by a mutation in the gene that makes hemoglobin, the protein in red blood cells that carries oxygen. This malformation hinders the cells’ ability to flow through blood vessels, leading to tissue and organ damage. “I’m going to hurt a specific place. Most of the time, I’m going to have back pain, chest, head,” says the little girl.

Imane is currently hospitalized in a care facility to receive blood transfusions which can relieve the chronic anemia and painful crises caused by the condition.

Sickle cell anemia is particularly prevalent among people of Caribbean, African, Mediterranean, Middle Eastern, and South American descent, as well as certain regions of India. It is estimated that one in ten Black Americans carry the sickle cell trait, which can lead to the disease if passed on to their children. According to the Centers for Disease Control and Prevention (CDC), sickle cell anemia affects approximately 100,000 Americans, with the majority being of African descent.

While sickle cell anemia has no cure, blood transfusions can mitigate the pain and anemia. Experts recommend that patients receive transfusions from donors with similar genetic backgrounds for optimal health outcomes. Naderge Ceneston, an advisor for the development of cultural communities at Héma-Québec, highlights the need for increased blood donations from Black communities, echoing the words of Ricki Fairman, a National Minority Organ and Tissue Partner: “We’re always crying for blood donors and it is important that individuals come out and understand that someone suffering from sickle cell is desperately in need of that blood.”

When you have to receive blood regularly, it is more beneficial to receive blood which has the same genetic baggage. This is where our request comes a little to want to mobilize people from the black communities, because they are the ones who are mainly affected by the disease, she underlines.

Naderge Ceneston, Advisor for the development of cultural communities at Héma-Québec

The Children’s Hospital in New Orleans has been actively employing new treatments for sickle cell patients, citing tremendous progress. Dr. Adam Johnson, a prominent hematologist at the Children’s Hospital said, “Thanks to new treatments like gene therapy and CRISPR- based therapies, we are achieving unprecedented results.”

Raising Awareness and Community Involvement

In recent years, health organizations have intensified their efforts to raise awareness and encourage community involvement in blood donation. This includes targeted outreach to ethnic and racial groups most affected by the disease. For example, the American Red Cross has launched campaigns specifically aimed at increasing blood donations from Black communities, understanding the vital role these donors play in saving lives.

Moreover, advancements in genetic testing and counseling have enabled early detection and management of sickle cell anemia. The American College of Obstetricians and Gynecologists recommends universal screening for the sickle cell trait during pregnancy, which has significantly improved prenatal care for affected families.

Addressing Challenges and Misconceptions

Despite these advancements, challenges remain. The cost of treatment is a significant barrier, and many patients struggle to afford the necessary care. Advocates are pushing for expanded insurance coverage and subsidized treatments to ensure all patients have access to life-saving therapies.

There are also misconceptions about sickle cell anemia that persist. Some people believe it is a rare condition and not as debilitating as it is. “But like many disabilities, the every person affected is unique, and many even participate in local and national sports or community services events!” Critical to Imanes community, and others, is looking how viable the treatments are.

Looking Ahead

Efforts to combat sickle cell anemia continue to gain momentum. Innovative therapies are being researched, and community awareness is growing. Governments are also focusing on policy changes to address the disease more comprehensively. With increased support and awareness, there is hope that more lives can be saved, improving the prognosis for those affected. As the CDC continues to push for genetic medicine, and doctors like Adam Johnson push new therapies, alternative options open up exciting potential to alleviate sickle cell infliction.